Mittwoch, 14. April 2021
Navigation öffnen
Anzeige:
Vectibix
JOURNAL ONKOLOGIE – STUDIE

Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

Rekrutierend

NCT-Nummer:
NCT04300257

Studienbeginn:
Oktober 2019

Letztes Update:
19.03.2020

Wirkstoff:
-

Indikation (Clinical Trials):
Sarcoma

Geschlecht:
Alle

Altersgruppe:
Alle

Phase:
-

Sponsor:
Kantonsspital Winterthur KSW, Kantonsspital Winterthur KSW

Collaborator:
SwissSarcomaNetwork, SwissSarcomaNetwork

Studienleiter

Bruno Fuchs, Prof
Principal Investigator
SwissSarcomaNetwork

Kontakt

Studienlocations
(1 von 1)

Studien-Informationen

Detailed Description:

Within the framework of interdisciplinary cooperation for a sarcoma problem, predictive and prognostic criteria will be developed that improve the treatment and particularly outcome.

The outcome variables include patient characteristics, tumor types and characteristics, histology, management and treatment strategies as well as recurrence rate and overall survival.
 

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN

- Female and male subjects of all ages

Exclusion Criteria:

- Documented objection of subsequent use of personal health data

Studien-Rationale

Primary outcome:

1. Diagnosis, (Time Frame - 5 years):
Data collected in the registry will be evaluated and analyzed to determine criteria to improve treatment strategies

2. Local recurrence, (Time Frame - 5 years):
s.o.

3. distant metastasis, (Time Frame - 5 years):
s.o.

4. biopsy taken by operating surgeon-radiologist-team, (Time Frame - 5 years):
s.o.

5. pathology centrally reviewed, (Time Frame - 5 years):
s.o.

6. Surgery (yes/no), (Time Frame - 5 years):
s.o.

7. Surgical margin status, (Time Frame - 5 years):
s.o.

8. surgery performed by dedicated surgeon, (Time Frame - 5 years):
s.o.

9. Radiation Therapy (yes/no), (Time Frame - 5 years):
s.o.

10. Chemotherapy (yes/no), (Time Frame - 5 years):
s.o.

11. decision of board carried out, (Time Frame - 5 years):
s.o.

12. Status at last contact, (Time Frame - 5 years):
s.o.

Quelle: ClinicalTrials.gov


Das könnte Sie auch interessieren